Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) has earned a consensus recommendation of "Hold" from the fourteen brokerages that are presently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $45.83.

A number of equities research analysts recently weighed in on the company. DZ Bank downgraded Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "hold" rating in a research report on Friday, July 29th. JPMorgan Chase & Co. dropped their price objective on Fresenius Medical Care AG & Co. KGaA from €51.00 ($52.04) to €23.00 ($23.47) in a research report on Monday, August 1st. UBS Group downgraded Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "neutral" rating in a research report on Friday, July 29th. Berenberg Bank dropped their price objective on Fresenius Medical Care AG & Co. KGaA from €76.70 ($78.27) to €57.95 ($59.13) in a research report on Wednesday, August 10th. Finally, Truist Financial lowered their price target on Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a "hold" rating for the company in a report on Wednesday, June 22nd.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. SRS Capital Advisors Inc. raised its stake in shares of Fresenius Medical Care AG & Co. KGaA by 36.0% in the first quarter. SRS Capital Advisors Inc. now owns 1,545 shares of the company's stock worth $52,000 after purchasing an additional 409 shares during the last quarter. Signaturefd LLC raised its stake in shares of Fresenius Medical Care AG & Co. KGaA by 26.4% in the first quarter. Signaturefd LLC now owns 2,190 shares of the company's stock worth $74,000 after purchasing an additional 458 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Fresenius Medical Care AG & Co. KGaA by 1.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 53,824 shares of the company's stock worth $1,747,000 after purchasing an additional 516 shares during the last quarter. Timber Creek Capital Management LLC raised its stake in shares of Fresenius Medical Care AG & Co. KGaA by 0.3% in the second quarter. Timber Creek Capital Management LLC now owns 199,285 shares of the company's stock worth $4,970,000 after purchasing an additional 542 shares during the last quarter. Finally, Wetherby Asset Management Inc. raised its stake in shares of Fresenius Medical Care AG & Co. KGaA by 9.0% in the first quarter. Wetherby Asset Management Inc. now owns 6,807 shares of the company's stock worth $229,000 after purchasing an additional 560 shares during the last quarter. 5.59% of the stock is currently owned by hedge funds and other institutional investors.

Fresenius Medical Care AG & Co. KGaA Price Performance

About Fresenius Medical Care AG & Co. KGaA

(Get Rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Stories

• Get a free copy of the StockNews.com research report on Fresenius Medical Care AG & Co. KGaA (FMS)
• Kroger's is Your One-Stop Consumer Staples Stock
• Adobe Perfects the Art of the Faceplant for Investors
• Tax Credits are the Incentives in the Inflation Reduction Act
• Stock Market: 3 Islands Of Strength In A Sea Of Red
• 3 Banks Worth Considering For Q4

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.